Cyclerion Therapeutics (CYCN) Cash & Current Investments (2019 - 2025)

Cyclerion Therapeutics' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $3.2 million for Q4 2025.

• In Q4 2025, Cash & Current Investments changed 0.25% year-over-year to $3.2 million; the TTM figure through Dec 2025 stood at $3.2 million (changed 0.25% YoY), while the FY2025 annual figure was $3.2 million, changed 0.25% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $3.2 million, down from $4.6 million in the prior quarter.
• The five-year high for Cash & Current Investments was $70.4 million in Q2 2021, with the low at $2.9 million in Q3 2024.
• The 5-year median for Cash & Current Investments is $7.4 million (2023), against an average of $19.7 million.
• The sharpest annual moves came in 2023 and 2025: Cash & Current Investments plunged 82.56% in 2023, then surged 59.05% in 2025.
• Cyclerion Therapeutics' Cash & Current Investments stood at $54.0 million in 2021, then slumped by 75.2% to $13.4 million in 2022, then tumbled by 43.42% to $7.6 million in 2023, then slumped by 57.31% to $3.2 million in 2024, then gained by 0.25% to $3.2 million in 2025.
• Business Quant data shows CYCN's Cash & Current Investments at $3.2 million in Q4 2025, $4.6 million in Q3 2025, and $3.0 million in Q2 2025.